首页> 外文OA文献 >Will co-trimoxazole resistance rates ever go down? Resistance rates remain high despite decades of reduced co-trimoxazole consumption
【2h】

Will co-trimoxazole resistance rates ever go down? Resistance rates remain high despite decades of reduced co-trimoxazole consumption

机译:复方新诺明耐药率是否会下降?尽管几十年减少了复方新诺明的消费量,耐药率仍然很高

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: Several studies showed that a substantial decline in the use of co-trimoxazole did not result in a decline in resistance rates among Escherichia coli isolates. Since mathematical models have shown that it may take decades before resistance rates start to decline to relevant levels, we performed a new analysis using more recently collected data. Methods: Data were extracted from Guy’s and St Thomas’ Hospitals Transmission and Antimicrobial Record database which contains microbiological test results from all specimens tested between 2002 and 2014. We selected all blood samples positive for E. coli which were tested for resistance against co-trimoxazole. Prevalence of co-trimoxazole resistance among the tested samples by year was modelled by a Poisson model. Results: Almost all (96%) of E. coli blood isolates were tested for co-trimoxazole resistance. In total, 2,070 E. coli isolates were available for analyses. Resistance to co-trimoxazole fluctuated over the years, but there was no clear increasing or decreasing trend; the annual percentage change in the prevalence of co-trimoxazole resistance was 0.52 (95% confidence interval −0.75% to 1.81%). Including co-trimoxazole or trimethoprim use in the year before the sample was taken did not improve the model. Conclusion: The prevalence of co-trimoxazole resistance among E. coli blood isolates remained high, almost three decades after a substantial decline in co-trimoxazole use. Our results further emphasize the importance of prudent antibiotics use, as antibiotic resistance may not always be easily reversible.
机译:目的:若干研究表明,使用共析氧唑的实质性下降并未导致大肠杆菌分离株的耐药率下降。由于数学模型表明,可能需要数十年的抵抗率开始衰落到相关级别,我们使用更多最近收集的数据进行了新的分析。方法:从Guy和ST托马斯的医院中提取数据和抗微生物记录数据库,含有来自2002和2014之间的所有标本的微生物测试结果。我们选择了所有对大肠杆菌阳性的血液样品,该血液样品被测试用于抗副氧化氧唑的抗性。通过泊松模型建模测试样品中的共析恶唑抗性的患病率。结果:测试几乎所有(96%)大肠杆菌血液分离物的血清唑抗性。总共有2,070%的大肠杆菌分离物用于分析。多年来,对共氧化氧唑的抵抗力波动,但没有明显的增加或降低趋势;共缩氧化唑抗性患病率的年百分比变化为0.52(95%置信区间-0.75%至1.81%)。在样品被采集之前的年份,包括共氧化氧唑或三甲基唑免药并未改善模型。结论:大肠杆菌血液分离株中共析唑抗性的患病率仍然很高,近三十年后,在共析氧唑的大幅下降后。我们的结果进一步强调了思考抗生素使用的重要性,因为抗生素抗性可能并不总是容易可逆的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号